Formyloxypivalinsaeure | 10066-60-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Formyloxypivalinsaeure
• 英文别名: 3-Formyloxy-2,2-dimethylpropanoic acid
• CAS: 10066-60-1
• 化学式: C₆H₁₀O₄
• mdl: MFCD19230564
• 分子量: 146.143
• InChiKey: DIBSHUBAVOOSDD-UHFFFAOYSA-N

物化性质

• 沸点：
  248.5±23.0 °C(Predicted)
• 密度：
  1.160±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  甲酸 、 2,2-二甲基-3-羟基丙酸 生成 Formyloxypivalinsaeure
  参考文献：
  名称：

  Merger,F., Chemische Berichte, 1968, vol. 101, p. 2413 - 2418

  摘要：

  DOI：

文献信息

• SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20220146931A1

  公开（公告）日：2022-05-12

  Disclosed are a salt represented by formula (I), an acid generator and a resist composition: wherein Q 1 and Q 2 each represent a fluorine atom or a perfluoroalkyl group; R 11 and R 12 each represent a hydrogen atom, a fluorine atom or a perfluoroalkyl group; z represents an integer of 0 to 6; X 1 and X 2 each represent *—CO—O—, *—O—CO—, etc.; L 1 represents a single bond or a hydrocarbon group which may have a substituent; A 1 represents a group having a lactone structure which may have a substituent; L 2 and L 3 each represent a single bond or an alkanediyl group; R 1 represents an iodine atom or a haloalkyl group; R 2 represents a halogen atom, a hydroxy group, a haloalkyl group or an alkyl group; m2 represents an integer of 0 to 4; and Z + represents an organic cation.

  公开了一种由式(I)表示的盐、酸发生剂和抗蚀组合物：其中Q1和Q2分别表示氟原子或全氟烷基；R11和R12分别表示氢原子、氟原子或全氟烷基；z表示0至6的整数；X1和X2分别表示*—CO—O—、*—O—CO—等；L1表示单键或可具有取代基的碳氢基团；A1表示具有内酯结构的基团，可能具有取代基；L2和L3分别表示单键或脂肪二烷基基团；R1表示碘原子或卤代烷基；R2表示卤原子、羟基、卤代烷基或烷基；m2表示0至4的整数；Z+表示有机阳离子。
• FUSED HETEROAROMATIC CYCLOPENTENE DERIVATIVE HAVING ENDOTHELIN-ANTAGONIST ACTIVITY
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP0714897A1

  公开（公告）日：1996-06-05

  A cyclopentene derivative represented by general formula (I) and a pharmaceutically acceptable salt thereof: wherein Ar¹ and Ar² represent each independently phenyl, thienyl, pyridyl, indolyl, benzofuranyl or dihydrobenzofuranyl; A represents a group that is combined with the adjacent carbon-carbon double bond to form a 5-or 6-membered heteroaromatic ring containing one to four heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur; and Y represents -CO-R⁴, SO₃H, PO₃H₂, tetrazol-5-yl, 2-oxo-3H-1,2,3,5-oxathiadiazol-4-yl or 5-oxo-4H-1,2,4-oxadiazol-3-yl.

  通式 (I) 所代表的环戊烯衍生物及其药学上可接受的盐：其中 Ar¹ 和 Ar² 各自独立地代表苯基、噻吩基、吡啶基、吲哚基、苯并呋喃基或二氢苯并呋喃基；A 代表一个基团，该基团与相邻的碳碳双键结合形成一个 5 或 6 元杂芳环，该环含有一至四个杂原子，这些杂原子选自由氮、氧和硫组成的组；Y 代表-CO-R⁴、SO₃H、PO₃H₂、四唑-5-基、2-氧代-3H-1,2,3,5-噁二唑-4-基或 5-氧代-4H-1,2,4-噁二唑-3-基。
• ENDOTHELIN ANTAGONISTS FOR TREATING HEART FAILURE
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP0906108B1

  公开（公告）日：2005-06-15
• TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
  申请人：TANABE SEIYAKU CO., LTD.

  公开号：EP1732924A2

  公开（公告）日：2006-12-20
• RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：US20200064735A1

  公开（公告）日：2020-02-27

  Disclosed are a resin containing a structural unit represented by formula (I), a structural unit represented by formula (a1-1), a structural unit represented by formula (a1-2) and a structural unit represented by formula (a2-A), and a resist composition including the same: